Normal view MARC view ISBD view

NICE guidance on pembrolizumab for advanced melanoma.

Watson, Ian

NICE guidance on pembrolizumab for advanced melanoma. [electronic resource] - The Lancet. Oncology Jan 2016 - 21-2 p. digital

Publication Type: News

ISSN: 1474-5488

Standard No.: 10.1016/S1470-2045(15)00547-1 doi

Subjects--Topical Terms:
Antibodies, Monoclonal, Humanized--therapeutic use
Antineoplastic Agents--therapeutic use
Cost-Benefit Analysis
Disease-Free Survival
Humans
Melanoma--drug therapy
Practice Guidelines as Topic
Randomized Controlled Trials as Topic
Survival Rate
United Kingdom

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)